The antimicrobial wound dressings market size to cross USD 1.5 billion by 2026, growing at a CAGR of 6% during the forecast period. The global market is witnessing the introduction of several advanced dressing materials. Chitosan is one of the natural polymers that hold promise for advanced antimicrobial agents. This polymer is a biodegradable and non-toxic material, which promotes rapid healing. Similarly, to combat bacterial infections, vendors have developed the cellulose membrane equipped with antimicrobial peptides. This skin-friendly membrane made of plant-based material kills the bacteria effectively and achieves an antibacterial effect. Hence, the introduction of innovative and advanced dressing materials is likely to have an impact on the market as they have proven healing capacities.
- Hydrogel dressings are expected to one of the fastest-growing segments during the forecast period due to better healing benefits and the presence of a highly hydrated 3D polymeric network.
- Chronic wounds are likely to observe an incremental growth of over $249 million by 2026 on account of an increase in chronic disorders.
- Specialty wound care centers are likely to grow at a CAGR of approx. 6% during the period 2020–2026.
- APAC is projected to observe the highest growth of over 7% during the period 2020–2026 due to the high prevalence of diabetes, with foot ulcer occurrence between 4% and 10%.
GLOBAL ANTIMICROBIAL WOUND DRESSINGS MARKET SEGMENTATION
This research report includes a detailed segmentation by
- Wound Type
INSIGHTS BY PRODUCT
Considered an ideal solution to maintain an optimal balance between moisture and bacterial growth, the demand for foam-based dressings is growing worldwide. These dressings are compliant with the existing wound care protocols as they are effective against gram-positive and gram-negative bacteria, along with fungi and yeast infections. With the rise in management of Antimicrobial wound dressings market size to cross USD 1.5 billion by 2026, growing at a CAGR of 6% during the forecast period. APAC is projected to observe the highest growth during the period 2020–2026. pressure ulcers, venous stasis ulcers, diabetic ulcers, donor sites, surgical wounds, abrasions, lacerations, dermatologic disorders, foam-based dressings are highly popular, thereby influencing market prospects.
The increasing prevalence of microbial infections, especially those associated with impaired wound healing and biomedical implant failure, has spurred the development of hydrogel dressings. The segment is expected to grow at the highest CAGR during the forecast period as hydrogel dressings consist of 90% water in the gel form, which helps to monitor fluid exchange from within the wound surface.
INSIGHTS BY WOUND TYPE
The rise in surgical site infections (SSI) is a key factor for the growth of acute wounds. The COVID-19 pandemic has exposed vulnerabilities in healthcare systems across the world and has adversely affected the global market. To reduce the risk of infections among patients and healthcare providers and conserve critical resources such as personal protective equipment (PPE), ventilators, and intensive care beds enacted a temporary ban on elective surgeries for a short period, which limits the usage of advanced wound care products. Moreover, the number of surgical procedures is increasing in the geriatric population as the elderly are prone to acute and chronic diseases, which need the usage of antimicrobial dressing materials worldwide.
Chronic wounds are a serious public health challenge, as they have high morbidity and mortality rates and are affecting an increasing number of people across the world. The usage of antimicrobial dressings among end-users is becoming popular to reduce infections and re-admissions in hospitals, especially in developed countries. As chronic abrasions are highly prone to several infections, the usage of antimicrobial dressing plays an important role in preventing infections and helping them recover fast. Hence, the rise in chronic wounds is likely to influence the market segment.
INSIGHTS BY END-USER
A high percentage of chronic wound patients are turning to hospitals for treatment as they are equipped with the latest machines and technology for diagnosing, treating, and healing wound conditions. All high-risk diabetic foot cases requiring intensive care services and major amputations take place in hospitals. Hence, the increase in diabetic foot cases is likely to augur well for the market. With the outbreak of COVID-19, patients opting for hospitals for wound management has decreased, which has reduced the demand for antimicrobial dressings temporarily. In 2020, specialty wound management clinics accounted for a share of over 26%. Non-healing wounds require specialized care due to underlying, complex conditions, which prevent abrasions from healing. The outbreak of the pandemic has brought specialty wound care clinics to prominence as most hospitals prioritize the treatment of COVID-19 patients.
INSIGHTS BY GEOGRAPHY
The US is a major revenue contributor to the global antimicrobial wound dressings market share. The usage of advanced wound care healing products in the country is higher than other countries across the world. The application of antimicrobial wound dressing materials is high as patients suffering from chronic and acute wounds are growing. For instance, in the United States, over 6.5 million patients are affected by chronic wounds, costing more than $50 billion annually. Chronic wounds represent a large and growing threat to public health in the US. Around 3% of the population over 65 years of age have open wounds. In 2020, the US government estimated that the elderly population is over 55 million, suggesting that chronic wounds will continue to be a persistent challenge. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. It is poised for significant growth on account of the growing geriatric population, the increase in accident and burn cases, and the high prevalence of diabetes.
INSIGHTS BY VENDORS
Smith+Nephew, Mölnlycke Health Care, ConvaTec, Coloplast, and 3M are key players operating in the market. These companies account for significant shares in the global antimicrobial wound dressings market. New product launches and strategic acquisitions and collaborations will be crucial to maintain revenue growth in the coming years. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. However, several tier-II and tier-III companies, including several Asian companies, are posing a threat to key players as they are offering antimicrobial dressings at competitive prices.
The global antimicrobial wound dressings market research report includes in-depth coverage of the competitive landscape, industry analysis with revenue, and forecast insights for the following segments:
- Specialty Wound Management Facilities
- Long-term Care Facilities
- Home Healthcare Settings
- North America
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa